CODRIX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Codrix, and what generic alternatives are available?
Codrix is a drug marketed by Watson Labs Florida and is included in three NDAs.
The generic ingredient in CODRIX is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Codrix
A generic version of CODRIX was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CODRIX?
- What are the global sales for CODRIX?
- What is Average Wholesale Price for CODRIX?
Summary for CODRIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 4 |
| DailyMed Link: | CODRIX at DailyMed |
US Patents and Regulatory Information for CODRIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Florida | CODRIX | acetaminophen; codeine phosphate | TABLET;ORAL | 040447-001 | Feb 26, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs Florida | CODRIX | acetaminophen; codeine phosphate | TABLET;ORAL | 040441-001 | Mar 27, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs Florida | CODRIX | acetaminophen; codeine phosphate | TABLET;ORAL | 040488-001 | Mar 28, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
